BioMerieux | DAIC

Skip to main content

Search this site

Eyebrow Menu

DIcardiology
Photo Galleries
Videos
- Videos
- Innovative Hospital Videos
Comparison Charts
Webinars
Blogs
- Blogs
- Blog Series
Calendar
Case Studies
Buyer's Guide
RESOURCES

Search this site

Sign In
New User? Register Here

FDA
COVID-19
Imaging
Cardiac Ultrasound

Computed Tomography (CT)

Contrast Media

Magnetic Resonance Imaging (MRI)

Nuclear Imaging

Radiation Dose management
Cath Lab
Angiography systems

Balloon catheters

FFR Technologies

Hemostasis management

Hemodynamic Support
Hybrid OR

Innovative Hospitals

Baylor Scott and White Heart Hospital

Henry Ford Hospital

Northwestern Medicine

Tufts Medical Center

University of Colorado Hospital

Intravascular imaging systems

Interventional radiology

Peripheral Artery Disease

Stents
EP Lab
Ablation systems

Atrial Fibrillation

Cardiac resynchronization therapy devices (CRT)

Implantable cardioverter defibrillators (ICD)

Leads, implantable devices

Pacemakers
Structural Heart
Congenital Heart

Heart Valve Technology

Hybrid OR

Left atrial appendage (LAA) occluders

Structural heart occluders/closure devices
Heart Failure
Stroke
Diagnostics
Blood Testing

ECG

Remote monitoring

Wearable Sensors
Pharma
Conference Coverage
ACC

AHA

AIMed

ASE

ASNC

EuroPCR

ESC

HIMSS

HRS

RSNA

SCAI

SCCT

STS

TCT

VIVA

Related Content

New Heart Failure Diagnostic Test Launched

October 1, 2007 - BioMerieux, a developer of in vitro diagnostics, announced the launch of VIDAS NT-proBNP, a CE ...

September 30, 2007

VIDEOS

DAIC Thought Leadership Series: The Importance of Inclusion in Clinical Trials

Comparison Charts

PACS Systems
Drug-Coated Balloons
Septal Occluders
Echocardiology Reporting Systems
TEVAR Stent Grafts

See All Comparison Charts

Bottom Menu

Topics We Cover
Advertise
Contact
Privacy Policy
Cookie Policy
Terms and Conditions
Sitemap

© Copyright Wainscot Media. All Rights Reserved.

Subscribe Now

E-newsletter subscription form